Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$7.37M |
| 2 |
Pfizer
PFE
|
+$4.11M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.87M |
| 4 |
Intel
INTC
|
+$2.69M |
| 5 |
Altria Group
MO
|
+$2.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.38M |
| 2 |
Philip Morris
PM
|
+$4.08M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.72M |
| 4 |
Medtronic
MDT
|
+$3.36M |
| 5 |
KLA
KLAC
|
+$3.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.65% |
| 2 | Financials | 13.38% |
| 3 | Healthcare | 13.2% |
| 4 | Communication Services | 9.9% |
| 5 | Consumer Staples | 8.25% |
Similar funds
Stoneridge Investment Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Stoneridge Investment Partners held 140 positions worth $238M, up 6.8% from $222M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Stoneridge Investment Partners withdrew a net $21.8M in Q2 2020, closing 29 positions and reducing 58 holdings. Its most notable exit was Philip Morris, an estimated $4.08M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Stoneridge Investment Partners opened a new position in Becton Dickinson worth $7.14M.
- Stoneridge Investment Partners's largest Q2 2020 buy was Becton Dickinson: 30,589 shares worth $7.14M.
- Stoneridge Investment Partners added most to Pfizer in Q2 2020, an estimated $4.11M increase.
- Stoneridge Investment Partners's biggest Q2 2020 reduction was Johnson & Johnson, cutting an estimated $4.38M.
- Stoneridge Investment Partners fully exited Philip Morris in Q2 2020, selling an estimated $4.08M.
- Stoneridge Investment Partners's ten largest holdings make up 35% of its $238M portfolio in Q2 2020.
- Stoneridge Investment Partners opened 26 new positions and closed 29 in Q2 2020.
- Stoneridge Investment Partners's portfolio value rose 6.8% quarter-over-quarter to $238M.
Based on Stoneridge Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.